Aimaz Afrough; Danai Dima; Beatrice Razzo; Utkarsh Goel; Aishwarya Sannareddy; Oren Pasvolsky; Mariola A. Vazquez-Martinez; Christopher J. Ferreri; Rahul Banerjee; Jack Khouri; James A. Davis; Mahmoud R. Gaballa; Alex Lieberman-Cribbin; Masooma S. Rana; Kelley Julian; Faiz Anwer; Leyla Shune; Shaun DeJarnette; Ariel F. Grajales-Cruz; Evguenia Ouchveridze; Gabriel De Avila; Sandra P. Susanibar-Adaniya; Andrew J. Portuguese; Daniel Schrum; Erin Eberwein; Hitomi Hosoya; Lekha Mikkilineni; Gurbakhash Kaur; Joseph P. McGuirk; Adriana Rossi; Megan M. Herr; Omar Castaneda; Frederick L. Locke; Shahzad Raza; Yi Lin; Shebli Atrash; Douglas W. Sborov; Peter M. Voorhees; Shambavi Richard; Alfred L. Garfall; Surbhi Sidana; Krina K. Patel; Doris K. Hansen; Andrew J. Cowan; Larry D. Anderson; Hans C. Lee

Linvoseltamab in Patients with Relapsed/Refractory Multiple Myeloma in the LINKER-MM1 Study: Longer Follow-Up and Subgroup Analyses

在LINKER-MM1研究中，复发/难治性多发性骨髓瘤患者的linvoseltamab治疗：更长时间的随访和亚组分析

Clinical Lymphoma Myeloma and Leukemia

IF2.7

2025-11-120

OAAI

Predictors of Delayed Responses to Teclistamab in Multiple Myeloma After Initial Non-Response

多发性骨髓瘤患者对特克替玛初始无应答后延迟应答的预测因子

American Journal of Hematology

IF9.9

2025-10-110

OAAI

Rahul Banerjee; Gurbakhash Kaur; Beatrice M. Razzo; Andrew J. Portuguese; Surbhi Sidana; Tiffany Richards; Ariel Grajales-Cruz; Shambavi Richard; Leyla Shune; Jack Khouri; Danai Dima; Hans C. Lee; Krina K. Patel; Oren Pasvolsky; Mariola Vazquez-Martinez; Doris K. Hansen; Aimaz Afrough; James A. Davis; Hamza Hashmi; Shebli Atrash; Christopher J. Ferreri; Kelley L. Julian; Megan M. Herr; Shonali Midha; Patrick Costello; Peter Forsberg; Andre de Menezes Silva Corraes; Yi Lin; Andrew J. Cowan; Larry D. Anderson Jr; Alfred L. Garfall

Outcomes of Patients with Multiple Myeloma with deletion 1p Following Autologous Stem Cell Transplant

多发性骨髓瘤患者伴有1p缺失行自体干细胞移植后的结局

Transplantation and Cellular Therapy

IF4.4

2025-08-050

PRE

Outcomes of teclistamab in patients with relapsed/refractory multiple myeloma with prior exposure to BCMA-directed therapy: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium

接受过BCMA靶向疗法的复发/难治性多发性骨髓瘤患者中teclistamab的治疗效果：一项来自美国多发性骨髓瘤免疫治疗联盟的多中心研究

Blood Cancer Journal

IF11.6

2025-06-250

OAAI

Danai Dima; Mariola A. Vazquez-Martinez; James A. Davis; Utkarsh Goel; Aimaz Afrough; Aishwarya Sannareddy; Oren Pasvolsky; Beatrice Razzo; Rahul Banerjee; Jack Khouri; Ariel Grajales-Cruz; Alex Lieberman-Cribbin; Masooma Shifa Rana; Kelley Julian; Shaun DeJarnette; Andrew J. Portuguese; Mahmoud R. Gaballa; Gabriel De Avila; Sandra Susaniba Adaniya; Shahzad Raza; Megan M. Herr; Evguenia Ouchveridze; Tiffany Richards; Hitomi Hosoya; Lekha Mikkilineni; Gurbakhash Kaur; Omar Castaneda Puglianini; Adriana Rossi; Yi Lin; Shebli Atrash; Douglas Sborov; Kenneth H. Shain; Peter M. Voorhees; Shambavi Richard; Alfred L. Garfall; Doris K. Hansen; Surbhi Sidana; Krina K. Patel; Andrew J. Cowan; Larry D. Anderson; Hans C. Lee; Faiz Anwer; Christopher J. Ferreri; Leyla Shune

Indirect Comparison of Linvoseltamab vs Teclistamab for the Treatment of Triple-Class Exposed Relapsed/Refractory Multiple Myeloma

三药耐药复发/难治性多发性骨髓瘤治疗中，林洛塞坦单抗与替西利单抗的间接比较

clinical lymphoma myeloma leukemia

IF0

2025-06-220

PREAI

Outcomes of Multiple Myeloma Patients With Prior Solid Tumors Undergoing Autologous Transplantation

多发性骨髓瘤患者既往有实体瘤病史行自体移植的结局

Transplantation and Cellular Therapy

IF4.4

2025-05-160

PRE

Outcomes of elderly patients with relapsed refractory multiple myeloma (RRMM) treated with teclistamab: a multicenter study from the US Multiple Myeloma Immunotherapy Consortium

复发难治性多发性骨髓瘤（RRMM）老年患者接受teclistamab治疗后的结局：一项来自美国多发性骨髓瘤免疫治疗联盟的多中心研究

BLOOD CANCER JOURNAL

IF11.6

2025-05-090

Pasvolsky, Oren; Dima, Danai; Feng, Lei; Dong, Wenli; Richards, Tiffany; Davis, James A.; Afrough, Aimaz; Vazquez-Martinez, Mariola; Sannareddy, Aishwarya; Goel, Utkarsh; Banerjee, Rahul; Khouri, Jack; Cervoni, Frances; Gaballa, Mahmoud R.; Lieberman-Cribbin, Alex; Rana, Masooma Shifa; Julian, Kelley; Ferreri, Christopher J.; Shune, Leyla; Dejarnette, Shaun; Bhurtel, Evguenia; Susanibar Adaniya, Sandra; Portuguese, Andrew; Hosoya, Hitomi; Mikkilineni, Lekha; Kaur, Gurbakhash; Rossi, Adriana; Herr, Megan M.; Schrum, Daniel; Lin, Chenyu; Raza, Shahzad; Lin, Yi; Midha, Shonali; Omar, Nadeem; Atarsh, Shebli; McGuirk, Joseph; Sborov, Douglas; Voorhees, Peter; Anwer, Faiz; Alsina, Melissa; Freeman, Ciara; Garfall, Alfred L.; Razzo, Beatrice M.; Sidana, Surbhi; Cowan, Andrew J.; Anderson Jr, Larry D.; Hansen, Doris K.; Richard, Shambavi; Patel, Krina K.; Lee, Hans C.; Grajales-Cruz, Ariel

NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025

NCCN Guidelines® Insights: 多发性骨髓瘤，版本 1.2025

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

IF16.4

2025-05-010

PRE

Kumar, Shaji K.; Callander, Natalie S.; Adekola, Kehinde; Anderson Jr, Larry D.; Baljevic, Muhamed; Baz, Rachid; Campagnaro, Erica; Costello, Caitlin; D'Angelo, Christopher; Derman, Benjamin; Devarakonda, Srinivas; Elsedawy, Noura; Godara, Amandeep; Godby, Kelly; Hillengass, Jens; Holmberg, Leona; Htut, Myo; Huff, Carol Ann; Hultcrantz, Malin; Kang, Yubin; Larson, Sarah; Lee, Hans C.; Liedtke, Michaela; Martin, Thomas; Omel, James; Robinson, Timothy; Rosenberg, Aaron; Schroeder, Mark A.; Sherbenou, Daniel; Suvannasankha, Attaya; Valent, Jason; Varshavsky-Yanovsky, Asya Nina; Vogl, Dan; Kovach, Emily; Kumar, Rashmi

The Impact of Melphalan Conditioning and CD34+ Cell Dose and Schedule on Post-Transplant Outcomes in AL Amyloidosis

美法仑预处理、CD34+细胞剂量及输注方案对AL型淀粉样变性移植后结局的影响

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2025-04-110

PRE

Single-cell analysis of neoplastic plasma cells identifies myeloma pathobiology mediators and potential targets

单细胞分析识别了恶性浆细胞的骨髓瘤病理生物学介质和潜在靶点

CELL REPORTS MEDICINE

IF10.6

2025-02-010

OAAI